Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding

IMPAACT 1077BF/FF PROMISE Study Team

Research output: Contribution to journalArticlepeer-review

Abstract

ABSTRACT: IMPAACT PROMISE 1077BF/FF was a sequentially randomized study of pregnant and postpartum women living with HIV to investigate the efficacy and safety of antiretroviral therapy (ART). This Maternal Health Component investigated efficacy for the risk of developing AIDS or death; and safety among women randomized to continue ART (CTART: N = 289) or discontinue ART (N = 268) after cessation of breastfeeding or after confirmation of infant infection. No AIDS-defining illnesses were reported during follow-up in either arm. Adverse events of grade 3 or higher were more frequent in the CTART arm [hazard ratio = 1.78, 95% confidence interval: (1.05 to 3.02), P-value = 0.03]. The difference in adverse events in the 2 groups was mostly driven by moderate weight loss for women on the CTART arm.

Original languageEnglish (US)
Pages (from-to)450-454
Number of pages5
JournalJournal of acquired immune deficiency syndromes (1999)
Volume86
Issue number4
DOIs
StatePublished - Apr 1 2021

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding'. Together they form a unique fingerprint.

Cite this